Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections.

Waters VJ, Kidd TJ, Canton R, Ekkelenkamp MB, Johansen HK, LiPuma JJ, Bell SC, Elborn JS, Flume PA, VanDevanter DR, Gilligan P; Antimicrobial Resistance International Working Group in Cystic Fibrosis.

Clin Infect Dis. 2019 May 6. pii: ciz364. doi: 10.1093/cid/ciz364. [Epub ahead of print]

PMID:
31056660
2.

Transmission of bacteria in bronchiectasis and chronic obstructive pulmonary disease: Low burden of cough aerosols.

Stockwell RE, Chin M, Johnson GR, Wood ME, Sherrard LJ, Ballard E, O'Rourke P, Ramsay KA, Kidd TJ, Jabbour N, Thomson RM, Knibbs LD, Morawska L, Bell SC.

Respirology. 2019 Mar 27. doi: 10.1111/resp.13544. [Epub ahead of print]

PMID:
30919511
3.

2-Hydroxylation of Acinetobacter baumannii Lipid A Contributes to Virulence.

Bartholomew TL, Kidd TJ, Sá Pessoa J, Conde Álvarez R, Bengoechea JA.

Infect Immun. 2019 Mar 25;87(4). pii: e00066-19. doi: 10.1128/IAI.00066-19. Print 2019 Apr.

4.

Abolition of Pseudomonas aeruginosa AUST-01 from an Australian CF center: Do other strains remain?

Kidd TJ, Grimwood K, Bell SC.

Pediatr Pulmonol. 2019 May;54(5):515-516. doi: 10.1002/ppul.24258. Epub 2019 Feb 11. No abstract available.

PMID:
30741479
5.

Correction: Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis.

Sherrard LJ, Tai AS, Wee BA, Ramsay KA, Kidd TJ, Ben Zakour NL, Whiley DM, Beatson SA, Bell SC.

PLoS One. 2019 Jan 14;14(1):e0210929. doi: 10.1371/journal.pone.0210929. eCollection 2019.

6.

Defining antimicrobial resistance in cystic fibrosis.

Kidd TJ, Canton R, Ekkelenkamp M, Johansen HK, Gilligan P, LiPuma JJ, Bell SC, Elborn JS, Flume PA, VanDevanter DR, Waters VJ; Antimicrobial Resistance in Cystic Fibrosis International Working Group.

J Cyst Fibros. 2018 Nov;17(6):696-704. doi: 10.1016/j.jcf.2018.08.014. Epub 2018 Sep 25. Review.

PMID:
30266518
7.

Expression of Pseudomonas aeruginosa Antibiotic Resistance Genes Varies Greatly during Infections in Cystic Fibrosis Patients.

Martin LW, Robson CL, Watts AM, Gray AR, Wainwright CE, Bell SC, Ramsay KA, Kidd TJ, Reid DW, Brockway B, Lamont IL.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01789-18. doi: 10.1128/AAC.01789-18. Print 2018 Nov.

8.

Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre.

Wee BA, Tai AS, Sherrard LJ, Ben Zakour NL, Hanks KR, Kidd TJ, Ramsay KA, Lamont I, Whiley DM, Bell SC, Beatson SA.

BMC Genomics. 2018 Aug 30;19(1):644. doi: 10.1186/s12864-018-5018-x.

9.

Face Masks Reduce the Release of Pseudomonas aeruginosa Cough Aerosols When Worn for Clinically Relevant Periods.

Stockwell RE, Wood ME, He C, Sherrard LJ, Ballard EL, Kidd TJ, Johnson GR, Knibbs LD, Morawska L, Bell SC; CF Cough Aerosol Group.

Am J Respir Crit Care Med. 2018 Nov 15;198(10):1339-1342. doi: 10.1164/rccm.201805-0823LE. No abstract available.

PMID:
30028634
10.

Transcriptomic analysis of longitudinal Burkholderia pseudomallei infecting the cystic fibrosis lung.

Price EP, Viberg LT, Kidd TJ, Bell SC, Currie BJ, Sarovich DS.

Microb Genom. 2018 Aug;4(8). doi: 10.1099/mgen.0.000194. Epub 2018 Jul 10.

11.

"Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic Fibrosis.

Gilligan PH, Downey DG, Elborn JS, Flume PA, Funk S, Gilpin D, Kidd TJ, McCaughan J, Millar BC, Murphy PG, Rendall JC, Tunney MM, Moore JE.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00193-18. doi: 10.1128/JCM.00193-18. Print 2018 Sep.

12.

Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the region.

Zowawi HM, Syrmis MW, Kidd TJ, Balkhy HH, Walsh TR, Al Johani SM, Al Jindan RY, Alfaresi M, Ibrahim E, Al-Jardani A, Al Salman J, Dashti AA, Sidjabat HE, Baz O, Trembizki E, Whiley DM, Paterson DL.

J Med Microbiol. 2018 Jun;67(6):846-853. doi: 10.1099/jmm.0.000730. Epub 2018 Apr 17.

PMID:
29664716
13.

Cystic fibrosis pathogens survive for extended periods within cough-generated droplet nuclei.

Wood ME, Stockwell RE, Johnson GR, Ramsay KA, Sherrard LJ, Kidd TJ, Cheney J, Ballard EL, O'Rourke P, Jabbour N, Wainwright CE, Knibbs LD, Sly PD, Morawska L, Bell SC.

Thorax. 2019 Jan;74(1):87-90. doi: 10.1136/thoraxjnl-2018-211567. Epub 2018 Apr 7.

PMID:
29627800
14.

P. aeruginosa blood stream infection isolates: A "full house" of virulence genes in isolates associated with rapid patient death and patient survival.

McCarthy KL, Wailan AM, Jennison AV, Kidd TJ, Paterson DL.

Microb Pathog. 2018 Jun;119:81-85. doi: 10.1016/j.micpath.2018.03.062. Epub 2018 Apr 3.

PMID:
29621565
15.

Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Tai AS, Sherrard LJ, Kidd TJ, Ramsay KA, Buckley C, Syrmis M, Grimwood K, Bell SC, Whiley DM.

BMC Pulm Med. 2017 Nov 2;17(1):138. doi: 10.1186/s12890-017-0482-7.

16.

Face Masks and Cough Etiquette Reduce the Cough Aerosol Concentration of Pseudomonas aeruginosa in People with Cystic Fibrosis.

Wood ME, Stockwell RE, Johnson GR, Ramsay KA, Sherrard LJ, Jabbour N, Ballard E, O'Rourke P, Kidd TJ, Wainwright CE, Knibbs LD, Sly PD, Morawska L, Bell SC.

Am J Respir Crit Care Med. 2018 Feb 1;197(3):348-355. doi: 10.1164/rccm.201707-1457OC.

PMID:
28930641
17.

Pseudomonas aeruginosa blood stream infection isolates from patients with recurrent blood stream infection: Is it the same genotype?

McCARTHY KL, Kidd TJ, Paterson DL.

Epidemiol Infect. 2017 Oct;145(14):3040-3046. doi: 10.1017/S0950268817001832. Epub 2017 Aug 22.

PMID:
28826423
18.

Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone.

López-Causapé C, Sommer LM, Cabot G, Rubio R, Ocampo-Sosa AA, Johansen HK, Figuerola J, Cantón R, Kidd TJ, Molin S, Oliver A.

Sci Rep. 2017 Jul 17;7(1):5555. doi: 10.1038/s41598-017-05621-5.

19.

Pseudomonas aeruginosa Infection after CFTR Restoration. One Step Back, One Step Forward.

Kidd TJ.

Am J Respir Crit Care Med. 2017 Jun 15;195(12):1550-1552. doi: 10.1164/rccm.201701-0220ED. No abstract available.

PMID:
28617081
20.

'Omic' Approaches to Study Uropathogenic Escherichia coli Virulence.

Lo AW, Moriel DG, Phan MD, Schulz BL, Kidd TJ, Beatson SA, Schembri MA.

Trends Microbiol. 2017 Sep;25(9):729-740. doi: 10.1016/j.tim.2017.04.006. Epub 2017 May 24. Review.

PMID:
28550944
21.

Tropical Australia is a potential reservoir of non-tuberculous mycobacteria in cystic fibrosis.

Sherrard LJ, Tay GT, Butler CA, Wood ME, Yerkovich S, Ramsay KA, Reid DW, Moore VL, Kidd TJ, Bell SC.

Eur Respir J. 2017 May 11;49(5). pii: 1700046. doi: 10.1183/13993003.00046-2017. Print 2017 May. No abstract available.

22.

Within-Host Evolution of Burkholderia pseudomallei during Chronic Infection of Seven Australasian Cystic Fibrosis Patients.

Viberg LT, Sarovich DS, Kidd TJ, Geake JB, Bell SC, Currie BJ, Price EP.

MBio. 2017 Apr 11;8(2). pii: e00356-17. doi: 10.1128/mBio.00356-17.

23.

Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis.

Sherrard LJ, Tai AS, Wee BA, Ramsay KA, Kidd TJ, Ben Zakour NL, Whiley DM, Beatson SA, Bell SC.

PLoS One. 2017 Mar 8;12(3):e0172179. doi: 10.1371/journal.pone.0172179. eCollection 2017. Erratum in: PLoS One. 2019 Jan 14;14(1):e0210929.

24.

Molecular epidemiology of Pseudomonas aeruginosa bloodstream infection isolates in a non-outbreak setting.

McCarthy KL, Kidd TJ, Paterson DL.

J Med Microbiol. 2017 Mar;66(2):154-159. doi: 10.1099/jmm.0.000413.

PMID:
28260586
25.

A Klebsiella pneumoniae antibiotic resistance mechanism that subdues host defences and promotes virulence.

Kidd TJ, Mills G, Sá-Pessoa J, Dumigan A, Frank CG, Insua JL, Ingram R, Hobley L, Bengoechea JA.

EMBO Mol Med. 2017 Apr;9(4):430-447. doi: 10.15252/emmm.201607336.

26.

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.

Bryant JM, Grogono DM, Rodriguez-Rincon D, Everall I, Brown KP, Moreno P, Verma D, Hill E, Drijkoningen J, Gilligan P, Esther CR, Noone PG, Giddings O, Bell SC, Thomson R, Wainwright CE, Coulter C, Pandey S, Wood ME, Stockwell RE, Ramsay KA, Sherrard LJ, Kidd TJ, Jabbour N, Johnson GR, Knibbs LD, Morawska L, Sly PD, Jones A, Bilton D, Laurenson I, Ruddy M, Bourke S, Bowler IC, Chapman SJ, Clayton A, Cullen M, Daniels T, Dempsey O, Denton M, Desai M, Drew RJ, Edenborough F, Evans J, Folb J, Humphrey H, Isalska B, Jensen-Fangel S, Jönsson B, Jones AM, Katzenstein TL, Lillebaek T, MacGregor G, Mayell S, Millar M, Modha D, Nash EF, O'Brien C, O'Brien D, Ohri C, Pao CS, Peckham D, Perrin F, Perry A, Pressler T, Prtak L, Qvist T, Robb A, Rodgers H, Schaffer K, Shafi N, van Ingen J, Walshaw M, Watson D, West N, Whitehouse J, Haworth CS, Harris SR, Ordway D, Parkhill J, Floto RA.

Science. 2016 Nov 11;354(6313):751-757. doi: 10.1126/science.aaf8156.

27.

The changing prevalence of pulmonary infection in adults with cystic fibrosis: A longitudinal analysis.

Ramsay KA, Sandhu H, Geake JB, Ballard E, O'Rourke P, Wainwright CE, Reid DW, Kidd TJ, Bell SC.

J Cyst Fibros. 2017 Jan;16(1):70-77. doi: 10.1016/j.jcf.2016.07.010. Epub 2016 Aug 8.

28.

A Novel Method and Its Application to Measuring Pathogen Decay in Bioaerosols from Patients with Respiratory Disease.

Johnson GR, Knibbs LD, Kidd TJ, Wainwright CE, Wood ME, Ramsay KA, Bell SC, Morawska L.

PLoS One. 2016 Jul 7;11(7):e0158763. doi: 10.1371/journal.pone.0158763. eCollection 2016.

29.

Methicillin-resistant Staphylococcus aureus acquisition in healthcare workers with cystic fibrosis: a retrospective cross-sectional study.

Wood ME, Sherrard LJ, Ramsay KA, Yerkovich ST, Reid DW, Kidd TJ, Bell SC.

BMC Pulm Med. 2016 May 11;16(1):78. doi: 10.1186/s12890-016-0243-z.

30.

Infection in cystic fibrosis: impact of the environment and climate.

Ramsay KA, Stockwell RE, Bell SC, Kidd TJ.

Expert Rev Respir Med. 2016;10(5):505-19. doi: 10.1586/17476348.2016.1162715. Epub 2016 Mar 28. Review. Erratum in: Expert Rev Respir Med. 2016 Jun;10 (6):713.

PMID:
26949990
31.

Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres.

Smith DJ, Ramsay KA, Yerkovich ST, Reid DW, Wainwright CE, Grimwood K, Bell SC, Kidd TJ.

Respirology. 2016 Feb;21(2):329-37. doi: 10.1111/resp.12714. Epub 2015 Dec 28.

32.

Genotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic Fibrosis.

Tai AS, Bell SC, Kidd TJ, Trembizki E, Buckley C, Ramsay KA, David M, Wainwright CE, Grimwood K, Whiley DM.

PLoS One. 2015 Dec 3;10(12):e0144022. doi: 10.1371/journal.pone.0144022. eCollection 2015.

33.

Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium.

Freschi L, Jeukens J, Kukavica-Ibrulj I, Boyle B, Dupont MJ, Laroche J, Larose S, Maaroufi H, Fothergill JL, Moore M, Winsor GL, Aaron SD, Barbeau J, Bell SC, Burns JL, Camara M, Cantin A, Charette SJ, Dewar K, Déziel É, Grimwood K, Hancock RE, Harrison JJ, Heeb S, Jelsbak L, Jia B, Kenna DT, Kidd TJ, Klockgether J, Lam JS, Lamont IL, Lewenza S, Loman N, Malouin F, Manos J, McArthur AG, McKeown J, Milot J, Naghra H, Nguyen D, Pereira SK, Perron GG, Pirnay JP, Rainey PB, Rousseau S, Santos PM, Stephenson A, Taylor V, Turton JF, Waglechner N, Williams P, Thrane SW, Wright GD, Brinkman FS, Tucker NP, Tümmler B, Winstanley C, Levesque RC.

Front Microbiol. 2015 Sep 29;6:1036. doi: 10.3389/fmicb.2015.01036. eCollection 2015.

34.

An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis.

Geake JB, Reid DW, Currie BJ, Bell SC; MelioidCF Investigators, Bright-Thomas R, Dewar J, Holden S, Simmonds N, Gyi K, Kenna D, Waters V, Jackson M, O'Sullivan B, Taccetti G, Kolbe J, O'Carroll M, Campbell D, Jaksic M, Radhakrishna N, Kidd TJ, Flight W.

BMC Pulm Med. 2015 Oct 9;15:116. doi: 10.1186/s12890-015-0109-9.

35.

The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.

Kidd TJ, Soares Magalhães RJ, Paynter S, Bell SC; ACPinCF Investigator Group.

Lancet Respir Med. 2015 Aug;3(8):640-50. doi: 10.1016/S2213-2600(15)00228-3. Epub 2015 Jul 22.

PMID:
26208994
36.

Whole-Genome Sequences of Five Burkholderia pseudomallei Isolates from Australian Cystic Fibrosis Patients.

Viberg LT, Price EP, Kidd TJ, Bell SC, Currie BJ, Sarovich DS.

Genome Announc. 2015 Apr 16;3(2). pii: e00254-15. doi: 10.1128/genomeA.00254-15.

37.

Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sources.

De Smet B, Mayo M, Peeters C, Zlosnik JE, Spilker T, Hird TJ, LiPuma JJ, Kidd TJ, Kaestli M, Ginther JL, Wagner DM, Keim P, Bell SC, Jacobs JA, Currie BJ, Vandamme P.

Int J Syst Evol Microbiol. 2015 Jul;65(7):2265-71. doi: 10.1099/ijs.0.000251. Epub 2015 Apr 14.

PMID:
25872960
38.

Evaluation of phenotypic screening tests for carbapenemase production in Pseudomonas aeruginosa from patients with cystic fibrosis.

Tai AS, Sidjabat HE, Kidd TJ, Whiley DM, Paterson DL, Bell SC.

J Microbiol Methods. 2015 Apr;111:105-7. doi: 10.1016/j.mimet.2015.02.006. Epub 2015 Feb 10.

PMID:
25680305
39.

Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years.

Kidd TJ, Ramsay KA, Vidmar S, Carlin JB, Bell SC, Wainwright CE, Grimwood K; ACFBAL Study Investigators.

J Cyst Fibros. 2015 May;14(3):361-9. doi: 10.1016/j.jcf.2014.12.007. Epub 2015 Jan 3.

40.

Molecular surveillance for carbapenemase genes in carbapenem-resistant Pseudomonas aeruginosa in Australian patients with cystic fibrosis.

Tai AS, Kidd TJ, Whiley DM, Ramsay KA, Buckley C, Bell SC; ACPinCF Investigator Group.

Pathology. 2015 Feb;47(2):156-60. doi: 10.1097/PAT.0000000000000216.

PMID:
25551306
41.

A comparison of two informative SNP-based strategies for typing Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Syrmis MW, Kidd TJ, Moser RJ, Ramsay KA, Gibson KM, Anuj S, Bell SC, Wainwright CE, Grimwood K, Nissen M, Sloots TP, Whiley DM.

BMC Infect Dis. 2014 Jun 5;14:307. doi: 10.1186/1471-2334-14-307.

42.

Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis.

Knibbs LD, Johnson GR, Kidd TJ, Cheney J, Grimwood K, Kattenbelt JA, O'Rourke PK, Ramsay KA, Sly PD, Wainwright CE, Wood ME, Morawska L, Bell SC.

Thorax. 2014 Aug;69(8):740-5. doi: 10.1136/thoraxjnl-2014-205213. Epub 2014 Apr 17.

43.

Developing an international Pseudomonas aeruginosa reference panel.

De Soyza A, Hall AJ, Mahenthiralingam E, Drevinek P, Kaca W, Drulis-Kawa Z, Stoitsova SR, Toth V, Coenye T, Zlosnik JE, Burns JL, Sá-Correia I, De Vos D, Pirnay JP, Kidd TJ, Reid D, Manos J, Klockgether J, Wiehlmann L, Tümmler B, McClean S, Winstanley C; EU FP7 funded COST Action BM1003 “Cell surface virulence determinants of cystic fibrosis pathogens”.

Microbiologyopen. 2013 Dec;2(6):1010-23. doi: 10.1002/mbo3.141. Epub 2013 Nov 11.

44.

Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis.

Ramsay KA, Butler CA, Paynter S, Ware RS, Kidd TJ, Wainwright CE, Bell SC.

J Clin Microbiol. 2013 Dec;51(12):3975-80. doi: 10.1128/JCM.01360-13. Epub 2013 Sep 18.

45.

Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection.

Price EP, Sarovich DS, Mayo M, Tuanyok A, Drees KP, Kaestli M, Beckstrom-Sternberg SM, Babic-Sternberg JS, Kidd TJ, Bell SC, Keim P, Pearson T, Currie BJ.

MBio. 2013 Jul 16;4(4). pii: e00388-13. doi: 10.1128/mBio.00388-13.

46.

Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis.

Ranganathan SC, Skoric B, Ramsay KA, Carzino R, Gibson AM, Hart E, Harrison J, Bell SC, Kidd TJ; Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST-CF) *.

Ann Am Thorac Soc. 2013 Apr;10(2):108-14. doi: 10.1513/AnnalsATS.201209-077OC.

PMID:
23607838
47.

High-throughput single-nucleotide polymorphism-based typing of shared Pseudomonas aeruginosa strains in cystic fibrosis patients using the Sequenom iPLEX platform.

Syrmis MW, Moser RJ, Kidd TJ, Hunt P, Ramsay KA, Bell SC, Wainwright CE, Grimwood K, Nissen MD, Sloots TP, Whiley DM.

J Med Microbiol. 2013 May;62(Pt 5):734-40. doi: 10.1099/jmm.0.055905-0. Epub 2013 Feb 14.

PMID:
23412772
48.

Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting.

Kidd TJ, Ritchie SR, Ramsay KA, Grimwood K, Bell SC, Rainey PB.

PLoS One. 2012;7(9):e44199. doi: 10.1371/journal.pone.0044199. Epub 2012 Sep 6.

49.

Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres.

Kidd TJ, Ramsay KA, Hu H, Marks GB, Wainwright CE, Bye PT, Elkins MR, Robinson PJ, Rose BR, Wilson JW, Grimwood K, Bell SC; ACPinCF Investigator Group.

Eur Respir J. 2013 May;41(5):1091-100. doi: 10.1183/09031936.00060512. Epub 2012 Aug 9.

50.

Clonal complex Pseudomonas aeruginosa in horses.

Kidd TJ, Gibson JS, Moss S, Greer RM, Cobbold RN, Wright JD, Ramsay KA, Grimwood K, Bell SC.

Vet Microbiol. 2011 May 5;149(3-4):508-12. doi: 10.1016/j.vetmic.2010.11.030. Epub 2010 Dec 1.

PMID:
21183294

Supplemental Content

Support Center